Curebound

Their Impact

An innovative funder and accelerator of cancer research with a vision of a world without cancer, Curebound intends to secure and award $100 million in collaborative research funding by 2031.

Our Role

Phoenix Philanthropy facilitated an extensive strategic planning that included working with a high-profile task force and interviews with leading cancer researchers, biomed industry leaders, venture philanthropists, and more. The three facilitated planning sessions resulted in an outstanding new vision and plan for the organization’s future. Currently assisting Curebound as it seeks to build a strong governance structure, enhance organizational capacity, and grow and diversify fundraising revenue.